Related Experiment Video
Updated: Jun 5, 2026

Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers
Published on: March 3, 2023
Adjunctive topical mesenchymal stem cell-derived secretome-enriched biological dressings in pediatric complex wounds:
José Ramón García-Lira1, Adriana Maria Valencia-Herrera1, Mirna Eréndira Toledo-Bahena1
1Department of Pediatric Dermatology, Federico Gómez Children's Hospital, Mexico City, Mexico.
Background:
Mesenchymal stem cell (MSC)-derived secretome, including extracellular vesicles (EVs), has emerged as a potential cell-free regenerative approach due to its immunomodulatory and tissue repair-associated properties. While topical applications have been explored in adult dermatologic settings, clinical evidence in pediatric patients with complex cutaneous wounds remains scarce.
Methods:
A retrospective observational case series was conducted at a tertiary referral pediatric hospital. Medical records and photographic documentation of six pediatric patients with complex cutaneous wounds treated with topical biological dressings containing MSC-derived secretome enriched in EVs were reviewed between January 2020 and January 2024. All patients received standard-of-care management in addition to adjunctive application of the biological dressings. Clinical evolution and treatment tolerability were assessed descriptively.
Results:
Progressive re-epithelialization and clinical improvement were observed across all cases based on clinical and photographic assessment. Time to complete re-epithelialization ranged from 6 to 14 days across heterogeneous wound etiologies. Estimated wound reduction ranged from approximately 85 to >90% at defined time points. No treatment-related adverse events were documented during follow-up.
Conclusion:
In this retrospective case series, progressive re-epithelialization was documented during follow-up in pediatric patients with complex cutaneous wounds receiving adjunctive topical MSC-derived secretome-enriched biological dressings alongside standard care. However, given the observational design, small sample size, heterogeneous diagnoses, and absence of a control group, these findings should be interpreted as descriptive and hypothesis-generating. Prospective, controlled studies are needed to better define the therapeutic role and safety profile of these interventions in pediatric regenerative dermatology.
Related Concept Videos
Clinical Applications of Epidermal Stem Cells
Mesenchymal Stem Cells